Syringe Coverage in an Australian Setting: Does a High Level of Syringe Coverage Moderate Syringe Sharing Behaviour?
详细信息 查看全文
- 作者：Joanne Bryant (1) j.bryant@unsw.edu.au
Dana Paquette (1)
Hannah Wilson (1) - 关键词：Injecting drug use – ; Syringe coverage – ; HIV – ; Hepatitis C – ; Australia
- 刊名：AIDS and Behavior
- 出版年：2012
- 出版时间：July 2012
- 年：2012
- 卷：16
- 期：5
- 页码：1156-1163
- 全文大小：196.8 KB
- 参考文献：1. Falck RS, Siegal HA, Wang J, Carlson RG. Usefulness of the health belief model in predicting HIV needle risk practices among injection drug users. AIDS Educ Prev. 1995;7:523–33.
2. Gibson DR, Choi KH, Catania JA, Sorenson JL, Kegeles S. Psychosocial predictors of needle sharing among intravenous drug users. Subst Use Misuse. 1993;28:973–81.
3. Neaigus A, Friedman SR, Kottiri BJ, Des Jarlais DC. HIV risk networks and HIV transmission among injecting drug users. Eval Prog Plan. 2001;24:221–6.
4. Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Ildefonso G. Street level drug markets: network structure and HIV risk. Soc Netw. 1995;17:229–49.
5. Loxley W. Double risk Young injectors and sexual relationships. Sex Relatsh The. 2000;15:297–310.
6. Rhodes T, Quirk A. Drug users’ sexual relationships and the social organisation of risk: the sexual relationship as a site of risk management. Soc Sci Med. 1998;2:157–69.
7. Tempalski B, Cooper HL, Friedman SR, Des Jarlais DC, Brady J, Gostnell K. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. Int J Drug Pol. 2008;19(suppl 1):47–58.
8. Da Fonseca EM, Ribeiro JM, Bertoni N, Bastos FI. Syringe exchange programs in Brazil: preliminary assessment of 45 programs. Cad Saude Publica. 2006;22(4):761–70.
9. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alc Dep. 2007;89(2–3):214–22.
10. Heller DI, Paone D, Sieglet A, Karpati A. The syringe gap: an assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City. Harm Red J. 2009;6:1. doi:
11. Burrows D. Advocacy and coverage of needle exchange programs: results of a comparative study of harm reduction programs in Brazil, Bangladesh, Belarus, Ukraine, Russian Federation, and China. Cad Saude Publica. 2006;22(4):871–9.
12. Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injecting drug users. Addiction. 2007;102(4):638–46.
13. Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injection risk behaviours among clients of syringe exchange programs with different syringe dispensation policies. JAIDS. 2004;37:1307–12.
14. Sharma M, Burrows D, Bluthenthal R. Coverage of HIV prevention programs for injection drug users: confusions, aspirations, definitions and ways forward. Int J Drug Pol. 2007;18:92–8.
15. Des Jarlais DC, Friedman SR. Fifteen years of preventing HIV infection among injecting drug users. What we have learned, what we have not learned, what we have done, what we have not done. Pub Health Rep. 1998;113:182–8.
16. Burrows D. Rethinking coverage of needle exchange programs. Sub Use Mis. 2006;41(6–7):1045–8.
17. WHO. Task force for the urgent response to the epidemics of sexually transmitted infections in eastern Europe and central Asia. Copenhagen: WHO Regional Office for Europe; 2000.
18. Suh T, Mandell W, Latkin C, Kim J. Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug Alc Dep. 1997;47(2):137–43.
19. Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, et al. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alc Dep. 1995;38(1):1–9.
20. Aceijas C, Hickman M, Donoghoe MC, Burrows D, Stuikyte R. Access and coverage of needle and syringe programmes (NSP) in central and eastern Europe and central Asia. Addiction. 2007;102(8):1244–50.
21. Heimer R. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange. Int J Drug Policy. 2008;19(suppl 1):65–73.
22. Thein H-H, Denoe M, van Beek I, Dore G, MacDonald M. Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int J Drug Policy. 2003;14:425–30.
23. Bryant J, Topp L, Hopwood M, Iversen J, Treloar C, Maher L. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south east Sydney. Drug Alc Rev. 2010;29(4):364–70.
24. Craine N, Hickman M, Parry JV, Smith J, McDonald T, Lyons M. Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution. J Pub Health. 2010;32(3):328–35.
25. Lorvick J, Bluthenthal R, Scott A, Gilbert ML, Riehman KS, Anderson RL, et al. Secondary syringe exchange among users of 23 California syringe exchange programs. Sub Use Mis. 2006;41:865–82.
26. Bryant J, Hopwood M. Secondary exchange of sterile injecting equipment in a high distribution environment: a mixed method analysis in south east Sydney, Australia. Int J Drug Pol. 2009;20:324–8.
27. National Centre in HIV Epidemiology and Clinical Research. Australian NSP survey national data report 2005–2009. Syndey: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2010.
28. Sarang A, Rhodes T, Platt L. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Pol. 2008;19(suppl 1):25–36.
29. Mathers B, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick R, et al. HIV prevention, treatment and care services for people who inject drugs: a systematic review of global, regional and national coverage. Lancet. 2010;375:1014–28.
30. NSW Department of Health. Needle and syringe program policy and guidelines for NSW 2006. NSW Department of Health, Sydney, NSW. http://www.health.nsw.gov.au/policies/pd/2006/PD2006_037.html.
31. Bryant J, Wilson H, Hull P, Treloar C. Pharmacy needle and syringe survey 2006–2008: New South Wales. Sydney: National Centre in HIV Social Research, The University of New South Wales; 2010.
32. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behaviour among active young injection drug users in San Francisco (the UFO Study). J Urb Health. 2003;80:137–46.
33. Miller CL, Strathdee SA, Spittal PM, Kerr T, Li K, Schecter M, et al. Elevated rates of HIV infection among young aboriginal injection drug users in a Canadian setting. Harm Red J. 2006;3:9.
34. Marshall B, Wood E, Li K, Kerr T. Elevated syringe borrowing among men who have sex with men: a prospective study. JAIDS. 2007;46(2):248–52.
35. Rondinelli A, Ouellet LJ, Strathdee S, Latka MH, Hudson SM, Hagan H, Garfein RS. Young adult injection drug users in the United States continue to practice HIV risk behaviours. Drug Alc Dep. 2009;104(1–2):167–74.
36. Aitken CA, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology. 2008;48(6):1746–52.
37. Roy E, Alary M, Morissette C, Leclerc P, Boudreau JF, Parent R, et al. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS. 2007;18:23–7.
38. Habib S. Understanding the context of risk practices among injecting drug users: implications for hepatitis C prevention. Aust J Soc Issues. 2003;38:1–17.
39. Vickerman P, Hickman M, Rhodes T, Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. JAIDS. 2006;42(3):355–61.
40. Kaplan E, O’Keefe E. Let the needles do the talking! Evaluating the new haven needle exchange. Interfaces. 1993;23(1):7–26.
41. Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J. Accuracy of perceptions of hepatitis B and C status: crosssectional investigation of opiate addicts in treatment. BMJ. 1999;319:290–1.
42. Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, et al. Self-reported hepatitis C virus antibody status and risk behaviour in young injectors. Pub Health Rep. 2006;121:710–9. - 作者单位：1. National Centre in HIV Social Research, The University of New South Wales, Sydney, NSW 2052, Australia
- 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Public Health
Health Psychology
Infectious Diseases - 出版者：Springer Netherlands
- ISSN：1573-3254
文摘
We examined individual-level syringe coverage among 417 people who inject drugs who were recruited from pharmacies in New South Wales in 2009. There was a U-shaped distribution of syringe coverage with many people having very high (51%) or very low (23%) coverage. Overall, two-thirds of respondents (63%) reported adequate coverage (≥100%). Respondents who had not used a needle and syringe program in the previous month were more likely to report inadequate coverage (AOR 2.25, 95% CI 1.25–4.05) as were those who reported daily or more frequent injecting (AOR 3.69, 95% CI 2.00–6.81). Inadequate syringe coverage was not independently associated with receptive needle sharing. The level of syringe coverage was high among this sample, and met targets set out by UNAIDS and other organisations. We found that inadequate syringe coverage was not independently correlated with receptive needle sharing, possibly because coverage is sufficient to diminish the relationship between syringe availability and sharing behaviours.